ARTICLE | Clinical News
Promacta eltrombopag regulatory update
May 4, 2009 7:00 AM UTC
GlaxoSmithKline disclosed that on March 19 it submitted an sNDA to FDA seeking full approval of Promacta eltrombopag to treat thrombocytopenia in patients with chronic idiopathic thrombocytopenic purp...